Clinical Presentation

Author(s):

Key Takeaways

Segmental vitiligo, typically stable and unilateral, may benefit from surgical interventions, while nonsegmental vitiligo often requires systemic therapies due to its bilateral and progressive nature.
Patient collaboration is vital in creating treatment plans, focusing on treatment goals, expectations, and potential side effects to ensure personalized care.
Challenges in managing vitiligo include addressing psychological impacts, managing patient expectations, and tailoring treatments to individual needs and disease characteristics.

Andrew Alexis, MD, MPH, discusses how, in creating individualized treatment plans for vitiligo, clinicians must carefully consider the distinct challenges and response patterns associated with segmental vs nonsegmental forms, as segmental vitiligo tends to be more stable after initial progression but often more resistant to treatment, while nonsegmental vitiligo typically shows a more unpredictable course requiring ongoing management strategies.

EP: 1.Collaborating With Communities to Manage Pediatric Vitiligo

EP: 2.Anticipating Advances for Pediatric Vitiligo

EP: 3.Telehealth and Research Strides for Young Patients

EP: 4.Managing Expectations and Holistically Treating Patients With Vitiligo

EP: 5.Vitiligo Repigmentation Challenges and Evaluating Treatment Success

Now Viewing

EP: 6.Clinical Presentation

EP: 7.Promising and Emerging Therapies in the Vitiligo Landscape

EP: 8.The JAK Revolution in Vitiligo

EP: 9.Balancing Safety and Efficacy With Key Data

Video content above is prompted by the following:

When you’re coming up with these treatment plans, how do differences in clinical presentation and, progression of segmental and nonsegmental vitiligo influence that plan when you’re creating it? How do you work with a patient to create a treatment plan?
When you approach segmental vitiligo vs nonsegmental forms, are there any specific challenges associated with each type?